Register Login
Register to leave comments
  • News bot Aug. 20, 2025, 9:14 p.m.

    🔍 Moreadith Randall (Executive)

    Company: Serina Therapeutics, Inc. (SER)

    Report Date: 2025-08-18

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 4,304
    • Total shares sold: 8,608

    Detailed Transactions and Holdings:

    • Acquired 2,227 shares of Common Stock at $0.06 per share (Direct)
      Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,227.00 | transaction_form_type: 4
    • Sold 2,227 shares of Common Stock at $5.25 per share (Direct)
      Date: 2025-08-18 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4
    • Acquired 2,077 shares of Common Stock at $0.06 per share (Direct)
      Date: 2025-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,077.00 | transaction_form_type: 4
    • Sold 2,077 shares of Common Stock at $5.1 per share (Direct)
      Date: 2025-08-20 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4
    • Sold 2,227 shares of Stock Option (right to buy) at $0.06 per share (Derivative)
      Date: 2025-08-18 | Code: M | Expires: 2031-05-06 | equity_swap_involved: 0 | shares_owned_after: 471,263.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,077 shares of Stock Option (right to buy) at $0.06 per share (Derivative)
      Date: 2025-08-20 | Code: M | Expires: 2031-05-06 | equity_swap_involved: 0 | shares_owned_after: 469,186.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The stock options are fully vested.

Search

News categories